Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Venkata Kashyap Yellepeddi obtained his Bachelor of Pharmacy degree from Kakatiya University, India in 2002. He later graduated with a PhD in Medical Sciences with a specialization in Pharmaceutics from Texas A&M Health Science Center, College Station, Texas in 2011.
Dr. Yellepeddi joined the Indian Institute of Chemical Technology in 2003 and worked as a Senior Research Fellow for three years. He was involved in research projects related to drug delivery, drug targeting, pre-clinical toxicology and pharmacokinetics. During his tenure as a Senior Research Fellow, he mentored students on various aspects of pharmaceutical research as part of an Indo-French student exchange program.
After enrolling in a graduate program in 2006, Dr. Yellepeddi conducted a National Institutes of Health, National Cancer Institute-funded research project on drug targeting to ovarian cancer using novel nanomaterials. He was also actively involved in the development of multifunctional nanodevices for treatment and resistance reversal in various cancers, nonviral gene delivery, synthesis and characterization of biopolymers, enhancement of oral permeability for drugs with poor biopharmaceutical properties and clinical pharmacokinetics of nanotechnology based formulations.
Dr. Yellepeddi joined College of Pharmacy, Roseman University of Health Sciences as an Assistant Professor of Pharmaceutical Sciences in 2012. Dr. Yellepeddi was also appointed as Adjunct Assistant Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, University of Utah in 2012. Dr. Yellepeddi served as visiting professor for teaching pharmaceutics course at Irma Lerma Rangel College of Pharmacy, Texas A&M University-Health Science Center, College Station, Texas. Dr. Yellepeddi published 16 original research publications, 4 book chapters, one book review and 22 abstracts at international conferences. Dr. Yellepeddi currently serves as a scientific reviewer for 21 scientific journals and serves as editorial board member for one journal. Dr. Yellepeddi after joining Roseman University, received three extramural grants from both non-profit foundations and private organizations.
My research focuses primarily on developing nanotechnology-based formulations for targeting therapeutics to tumors. My research also focuses on the development and pharmacokinetic evaluation of formulations to overcome various physiological barriers (nasal, periodontal, skin, corneal etc.). In my lab, we are developing various nanotechnology-based delivery systems to target drugs/macromolecules to resistant-tumors, to overcome the blood-brain barrier in diseases like migraine and cerebral palsy, and to overcome gastrointestinal epithelial barrier. The other areas of my research interests include population pharmacokinetics and modeling of drugs used in special populations; formulation and evaluation of sterile and non-sterile extemporaneously compounded preparations; biopharmaceutic and pharmacokinetic evaluation of new chemical entities (NCE's); and development of technology-based visual aids for the teaching pharmaceutics and pharmacokinetics.
Research Article: J Biotechnol Biomaterial 2013, S13:003
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals